Allogene Therapeutics, Inc. (ALLO) vs CorMedix Inc (CRMD)
Allogene Therapeutics, Inc. and CorMedix Inc are both Biotechnology companies. Allogene Therapeutics, Inc. and CorMedix Inc are of similar size ($608.0M and $594.2M). Allogene Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; CorMedix Inc trades at 3.3×. Allogene Therapeutics, Inc. grew revenue faster over the last twelve months: 7,613.1% against 280.5%. CorMedix Inc has the higher net margin (40.5% vs −3,517.4%) and the higher return on invested capital (38.8% vs −108.8%). Across the 17 metrics below, CorMedix Inc leads on 12 and Allogene Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ALLO | CRMD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 82.78% | 65.16% |
| Operating margin | (3,832.45%) | 46.95% | 0.00% |
| Net margin | (3,517.41%) | 40.49% | 0.00% |
| Free cash flow margin | (2,180.62%) | 54.17% | 0.00% |
| Return on equity | (42.39%) | 54.93% | (57.72%) |
| Return on assets | (32.43%) | 32.36% | (49.22%) |
| Return on invested capital | (108.81%) | 38.84% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack